fair value 8.08, page-4

I think every investor has their fingers crossed. Really just two numbers (in the 2nd quarter) will determine how the market reacts.

Sentiment has turned around based on;

• The increase in revenue from Nextstellis (after a flat FY 23) reported revenue grew from $3.8m to $6.4m (us) - this is huge!! if they can maintain this growth we see positive signs for the first time since they acquired the reseller rights.
• The turn around of Dermatology; a $7.5m (us) turnaround (from -$1m to +$6.5m) - MYX need to sustain this; we saw what happened to the SP when those numbers crashed on the back of accounting irregularities (12 months ago rev $84m contributing $34m (us) - until all hell broke loose and the numbers were restated!).

Let's hope it continues